文献速递药物不良反应与药物警戒

选择性5-羟色胺再摄取抑制剂报告的不良药物反应性别差异

Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors.
PubMed 文献 · Drug Saf · 2018-01-01

该研究基于荷兰药物警戒中心Lareb数据库,探索性分析男女性使用选择性5-羟色胺再摄取抑制剂(SSRIs)后报告的不良药物反应(ADRs)是否存在差异。计算经使用者数量校正后的女性与男性报告比值,发现16种ADRs在女性中报告显著更多,4种在男性中报告更多。女性更多报告的ADRs通常为剂量相关或常见ADRs,SSRIs药代动力学的性别差异可能解释此现象。

要点

  • 女性使用SSRIs时剂量相关或常见ADRs报告多于男性。
  • 荷兰Lareb数据库显示16种ADRs女性报告显著更多,4种男性更多。
  • 药代动力学性别差异可能是女性剂量相关ADRs更多的原因。

核心结论

  • 女性使用SSRIs时报告剂量相关或常见ADRs多于男性,药代动力学性别差异可能是原因。

研究设计与样本

  • 基于荷兰药物警戒中心Lareb数据库的探索性研究,计算经使用者数量校正的女性与男性报告比值。

主要发现

  • 16种ADRs在女性中报告有统计学显著增多,4种ADRs在男性中报告更多。

关键数值与推荐

  • 女性与男性报告比值经使用者数量校正后计算,16种ADRs女性显著更多,4种男性更多。

临床怎么用

  • 临床对女性使用SSRIs时应关注剂量相关或常见ADRs的报告信号。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Several studies have investigated sex as a risk factor for the occurrence of adverse drug reactions (ADRs) and found that women are more likely to experience ADRs than men. OBJECTIVE: The aim of this explorative study was to investigate whether differences exist in reported ADRs of selective serotonin reuptake inhibitors (SSRIs) for men and women in the database of the Netherlands Pharmacovigilance Centre Lareb. METHODS: A ratio of reports concerning women and men, corrected for the number of users, was calculated for all the ADRs reported on SSRIs. RESULTS: We found that 16 ADRs were statistically significantly more reported in women than men, and four ADRS were reported more in men than women. CONCLUSION: ADRs more reported in women than men when using SSRIs were usually dose-related ADRs or commonly occurring ADRs. Differences in the pharmacokinetics of SSRIs between men and women may explain why these reports of dose-related ADRs when using SSRIs concern women more than men.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Ekhart C, van Hunsel F, Scholl J, et al. Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors. Drug Saf. 2018. PMID: 29484612. doi:10.1007/s40264-018-0646-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。